Spots Global Cancer Trial Database for dna damage
Every month we try and update this database with for dna damage cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas | NCT01051635 | Neoplasms Lymphoma | LMP400 LMP776 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas | NCT01851369 | Lymphomas Solid Tumors NSCLC Metastatic Colo... Granulosa Cell ... | TRC102 CT scan Lomotil Prochlorperazin... Metoclopramide 5-HT3 antagonis... Aprepitant Biopsy | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Study of Tumour Response to Tirapazamine During Treatment of Cervical Cancer | NCT00493376 | Cervix Cancer | Cervical tissue... Biopsy: Measure... Biopsy: Immunoh... Measurement of ... | 18 Years - | British Columbia Cancer Agency | |
| Chromosomal Damage in Type 2 Diabetes Patients (MIKRODIAB) | NCT02231736 | Type 2 Diabetes Cancer | 30 Years - | University of Vienna | ||
| Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas | NCT03030417 | Solid Tumors Lymphoma | LMP744 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Indenoisoquinoline LMP400 for Advanced Solid Tumors and Lymphomas | NCT01794104 | Neoplasm Lymphoma | LMP400 | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Nutritional Intervention and DNA Damage of Patients With HBOC | NCT05306002 | HBOC Syndrome DNA Damage Nutrition Thera... | Antioxidant the... | 18 Years - | Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | |
| ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancer | NCT01445522 | Neoplasms Lymphoma | ABT-888 Cyclophosphamid... | 18 Years - 110 Years | National Institutes of Health Clinical Center (CC) | |
| Rehabilitation Assessment and Progress Tracking System Based on Video Images for Dysphagic Patients | NCT05141539 | Healthy Head and Neck C... | Rehabilitation ... VFSS and FOIS | 18 Years - 80 Years | Mahidol University | |
| Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations | NCT01989546 | Advanced Ovaria... Primary Periton... Advanced Breast... Advanced Solid ... | BMN 673 | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| SU5416 and Carboplatin to Treat Ovarian Cancer | NCT00006155 | Fallopian Tube ... Ovarian Cancer Peritoneal Neop... | SU5416 and carb... | - | National Institutes of Health Clinical Center (CC) | |
| Predictive Biomarkers for Response to Nivolumab in Head and Neck Squamous Cell Carcinoma | NCT03652142 | HNSCC DNA Damage DNA Double Stra... | Biomarker Resea... Nivolumab | 18 Years - | Attikon Hospital | |
| Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations | NCT01989546 | Advanced Ovaria... Primary Periton... Advanced Breast... Advanced Solid ... | BMN 673 | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors | NCT03875313 | Solid Tumor Clear Cell Rena... TNBC - Triple-N... Colorectal Canc... CRC RCC ccRCC | CB-839 Talazoparib | 18 Years - | Calithera Biosciences, Inc | |
| TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas | NCT01851369 | Lymphomas Solid Tumors NSCLC Metastatic Colo... Granulosa Cell ... | TRC102 CT scan Lomotil Prochlorperazin... Metoclopramide 5-HT3 antagonis... Aprepitant Biopsy | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| The Effects of Foods on Cell Damage Study | NCT02696811 | DNA Damage Inflammation | White carrots Oat biscuits | 45 Years - | Newcastle University | |
| Prevention of Oral DNA Damage by Black Raspberries | NCT04372914 | Oral Cancer Smoking DNA Damage Oxidative Stres... | BRB Lozenges | 21 Years - 75 Years | Milton S. Hershey Medical Center | |
| Garlic Intake And Biomarkers Of Cancer Risk | NCT01293591 | Healthy Men Healthy Women | Control Garlic treatmen... | 40 Years - 80 Years | USDA Beltsville Human Nutrition Research Center | |
| Indenoisoquinoline LMP400 for Advanced Solid Tumors and Lymphomas | NCT01794104 | Neoplasm Lymphoma | LMP400 | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| Rehabilitation Assessment and Progress Tracking System Based on Video Images for Dysphagic Patients | NCT05141539 | Healthy Head and Neck C... | Rehabilitation ... VFSS and FOIS | 18 Years - 80 Years | Mahidol University | |
| Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors | NCT03875313 | Solid Tumor Clear Cell Rena... TNBC - Triple-N... Colorectal Canc... CRC RCC ccRCC | CB-839 Talazoparib | 18 Years - | Calithera Biosciences, Inc | |
| The Effects of Replacing Red and Processed Meat With Quorn on Biomarkers of Gut Health | NCT03944421 | Colorectal Canc... | Red and Process... Quorn | 18 Years - 50 Years | Northumbria University | |
| Xanthohumol and Prevention of DNA Damage | NCT02432651 | Oxidative Stres... | 6 mg xanthohumo... 12 mg xanthohum... 24 mg xanthohum... Placebo | 18 Years - 50 Years | Oregon State University | |
| Rehabilitation Assessment and Progress Tracking System Based on Video Images for Dysphagic Patients | NCT05141539 | Healthy Head and Neck C... | Rehabilitation ... VFSS and FOIS | 18 Years - 80 Years | Mahidol University | |
| Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations | NCT01989546 | Advanced Ovaria... Primary Periton... Advanced Breast... Advanced Solid ... | BMN 673 | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| SU5416 and Carboplatin to Treat Ovarian Cancer | NCT00006155 | Fallopian Tube ... Ovarian Cancer Peritoneal Neop... | SU5416 and carb... | - | National Institutes of Health Clinical Center (CC) | |
| Prevention of Oral DNA Damage by Black Raspberries | NCT04372914 | Oral Cancer Smoking DNA Damage Oxidative Stres... | BRB Lozenges | 21 Years - 75 Years | Milton S. Hershey Medical Center | |
| A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas | NCT01051635 | Neoplasms Lymphoma | LMP400 LMP776 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Chromosomal Damage in Type 2 Diabetes Patients (MIKRODIAB) | NCT02231736 | Type 2 Diabetes Cancer | 30 Years - | University of Vienna | ||
| ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancer | NCT01445522 | Neoplasms Lymphoma | ABT-888 Cyclophosphamid... | 18 Years - 110 Years | National Institutes of Health Clinical Center (CC) | |
| Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRT | NCT04081428 | Prostate Cancer Radiotherapy Si... Volatile Organi... DNA Damage | Stereotactic Bo... | 18 Years - 80 Years | NHS Lothian |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
